论文部分内容阅读
Aims: To determine risk factors for development of microa-lbuminuria (MA) in relation to detection of limited joint mobility (LJM+ ) of the interphalangeal joints in a longitudinal cohort of type 1 diabetic (T1DM) subjects. Methods: A total of 479 T1DM subjects diagnosed <16 years were followed from diagnosis of diabetes with annual assessments consisting of assessment of LJM, measurement of HbA1c and insulin-like growth factor 1 (IGF-1), and three urine samples for albumin: creatinine ratio (ACR). Results: After a median follow up of 10.9 years, 162 subjects (35.1% ) developed LJM at median age 13.0 years and duration 5.2 years. More subjects developed LJM after compared to before puberty (67.6 v 32.4% ). In LJM+ compared to LJM-subjects, HbA1c (mean 10.1 (SD 1.6) v 9.6 (1.4) % )) and ACR levels (median 1.1 (range 0.2-242.9) v 0.9 (0.4-70.7) mg/mmol) were higher, and in a Cox model probability of developing LJM was related to puberty and higher HbA1c levels. ACR levels were higher after detection of LJM compared to before (median 1.2 (range 0.4-102.6) v 0.8 (0.2-181.9) mg/mmol). Probability of developing MA was related to puberty,HbA1c, female sex, and presence of LJM(a 1.9-fold increased risk). Both LJM and MA were associated with lower height SDS (LJM: mean 0.0 (SD 1.0) v 0.2 (1.1); MA: 0.0 (1.0) v 0.2 (SD 1.0)) and lower IGF-1 levels. Conclusion: The development of LJM was associated with an increased risk of microalbuminuria, independent of glycaemic control. Risk for both microalbuminuria and LJM was associated with puberty, reduced growth, and reduced IGF-1 levels, and may indicate underlying shared pathogenic mechanisms.
Aims: To determine risk factors for development of microa-albuminuria (MA) in relation to detection of limited joint mobility (LJM +) of the interphange joints in a longitudinal cohort of type 1 diabetic (T1DM) subjects. Methods: A total of 479 T1DM subjects diagnosed <16 years were followed from diagnosis of diabetes with annual assessment consisting of assessment of LJM, measurement of HbA1c and insulin-like growth factor 1 (IGF-1), and three urine samples for albumin: creatinine ratio (ACR). More subjects developed LJM after compared to before puberty (67.6 v 32.4%). In LJM + compared to LJM- (mean 10.1 (SD 1.6) v 9.6 (1.4)%)) and ACR levels (median 1.1 (range 0.2-242.9) v 0.9 (0.4-70.7) mg / mmol) were higher, and in a Cox model probability of developing LJM was related to puberty and higher HbA1c levels. ACR levels were higher aft (median 1.2 (range 0.4-102.6) v 0.8 (0.2-181.9) mg / mmol). Probability of developing MA was related to puberty, HbAlc, female sex, and presence of LJM (a 1.9- fold increased risk. Both LJM and MA were associated with lower height SDS (LJM: mean 0.0 (SD 1.0) v 0.2 (1.1); MA: 0.0 (1.0) v 0.2 (SD 1.0) Conclusion: The development of LJM was associated with an increased risk of microalbuminuria, independent of glycaemic control. Risk for both microalbuminuria and LJM was associated with puberty, reduced growth, and reduced IGF-1 levels, and may indicate underlying shared pathogenic mechanisms.